Molecular mechanisms and clinical implications of bacterial persistence

Drug Resistance Updates

Volumn 29, Issue , 2016, Pages 76-89

  Michiels, Joran Elie ^a   Van den Bergh, Bram ^a   Verstraeten, Natalie ^a   Michiels, Jan ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antibiotic tolerance; Chronic infections; Pathogens; Persisters; Resistance

Indexed keywords

ANTIBIOTIC AGENT; ANTITOXIN; TOXIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL PERSISTENCE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIRULENCE; ENVIRONMENTAL FACTOR; HUMAN; IN VIVO STUDY; NOISE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESUSCITATION; STRESS; TREATMENT FAILURE; BACTERIUM; CELL CLONE; DRUG EFFECTS; DRUG RESISTANCE; GENETIC HETEROGENEITY; GENETIC SELECTION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; GROWTH, DEVELOPMENT AND AGING; MARKOV CHAIN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION; NEOPLASM; PATHOLOGY; PHYSIOLOGICAL STRESS; TOXIN-ANTITOXIN SYSTEM;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CLONE CELLS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, NEOPLASM; GENE-ENVIRONMENT INTERACTION; GENETIC HETEROGENEITY; HUMANS; MUTATION; NEOPLASMS; PHENOTYPE; SELECTION, GENETIC; STOCHASTIC PROCESSES; STRESS, PHYSIOLOGICAL; TOXIN-ANTITOXIN SYSTEMS;

EID: 84992481960     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2016.10.002     Document Type: Article

References (196)

1. Ackermann, M., A functional perspective on phenotypic heterogeneity in microorganisms. Nat. Rev. Microbiol. 13 (2015), 497–508.
2. Adams, K., Takaki, K., Connolly, L., Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145 (2011), 39–53.
3. Al Mamun, A.A.M., Lombardo, M., Shee, C., Lisewski, A.M., Gonzalez, C., Lin, D., Nehring, R.B., Saint-ruf, C., Gibson, J.L., Frisch, R.L., Lichtarge, O., Hastings, P.J., Rosenberg, S.M., Identity and function of a large gene network underlying mutagenic repair of DNA breaks. Science 338 (2012), 1344–1348.
4. Allison, K.R., Brynildsen, M.P., Collins, J.J., Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 14 (2011), 593–598.
5. Allison, K.R., Brynildsen, M.P., Collins, J.J., Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473 (2011), 216–220.
6. Amato, S.M., Brynildsen, M.P., Persister heterogeneity arising from a single metabolic stress. Curr. Biol. 25 (2015), 2090–2098.
7. Amato, S.M., Brynildsen, M.P., Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLOS ONE, 9, 2014, e93110.
8. Amato, S.M., Orman, M.A., Brynildsen, M.P., Metabolic control of persister formation in Escherichia coli. Mol. Cell 50 (2013), 475–487.
9. Arnoldini, M., Vizcarra, I.A., Peña-Miller, R., Stocker, N., Diard, M., Vogel, V., Beardmore, R.E., Hardt, W.-D., Ackermann, M., Bistable expression of virulence genes in Salmonella leads to the formation of an antibiotic-tolerant subpopulation. PLoS Biol., 12, 2014, e1001928.
10. Balaban, N.Q., Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr. Opin. Genet. Dev. 21 (2011), 768–775.
11. Balaban, N.Q., Merrin, J., Chait, R., Kowalik, L., Leibler, S., Bacterial persistence as a phenotypic switch. Science 305 (2004), 1622–1625.
12. Barraud, N., Buson, A., Jarolimek, W., Rice, S.A., Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms. PLOS ONE, 8, 2013, e84220.
13. Barth, V.C., Rodrigues, B.Á., Bonatto, G.D., Gallo, S.W., Pagnussatti, V.E., Ferreira, C.A.S., de Oliveira, S.D., Heterogeneous persister cells formation in Acinetobacter baumannii. PLOS ONE, 8, 2013, e84361.
14. Beaber, J.W., Hochhut, B., Waldor, M.K., SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427 (2004), 72–74.
15. Bhargava, N., Sharma, P., Capalash, N., Pyocyanin stimulates quorum sensing-mediated tolerance to oxidative stress and increases persister cells population in Acinetobacter baumannii. Infect. Immun. 8 (2014), 3417–3425.
16. Bigger, J., Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244 (1944), 497–500.
17. Bjedov, I., Tenaillon, O., Gérard, B., Souza, V., Denamur, E., Radman, M., Taddei, F., Matic, I., Stress-induced mutagenesis in bacteria. Science 300 (2003), 1404–1409.
18. Black, D.S., Kelly, A.J., Mardis, M.J., Moyed, H.S., Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 173 (1991), 5732–5739.
19. Bojsen, R., Regenberg, B., Gresham, D., Folkesson, A., A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations. Sci. Rep., 6, 2016, 21874.
20. Bommarius, B., Anyanful, A., Izrayelit, Y., Bhatt, S., Cartwright, E., Wang, W., Swimm, A.I., Benian, G.M., Schroeder, F.C., Kalman, D., A family of indoles regulate virulence and Shiga toxin production in pathogenic E. coli. PLOS ONE, 8, 2013, e54456.
21. Brauner, A., Fridman, O., Gefen, O., Balaban, N.Q., Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat. Rev. Microbiol. 14 (2016), 320–330.
22. Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J.-P., Defraine, V., Michiels, J., Cenens, W., Aertsen, A., Miller, S., Lavigne, R., Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58 (2014), 3774–3784.
23. Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., Bandow, J.E., Sahl, H.-G., Labischinski, H., Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat. Med. 11 (2005), 1082–1087.
24. Bryk, R., Gold, B., Venugopal, A., Singh, J., Samy, R., Pupek, K., Cao, H., Popescu, C., Gurney, M., Hotha, S., Cherian, J., Rhee, K., Ly, L., Converse, P.J., Ehrt, S., Vandal, O., Jiang, X., Schneider, J., Lin, G., Nathan, C., Selective killing of nonreplicating mycobacteria. Cell Host Microbe 3 (2008), 137–145.
25. Cara, S., Tannock, I.F., Retreatment of patients with the same chemotherapy: implications for clinical mechanisms of drug resistance. Ann. Oncol. 12 (2001), 23–27.
26. Cataudella, I., Sneppen, K., Gerdes, K., Mitarai, N., Conditional cooperativity of toxin–antitoxin regulation can mediate bistability between growth and dormancy. PLoS Comput. Biol., 9, 2013, e1003174.
27. Cataudella, I., Trusina, A., Sneppen, K., Gerdes, K., Mitarai, N., Conditional cooperativity in toxin–antitoxin regulation prevents random toxin activation and promotes fast translational recovery. Nucleic Acids Res. 40 (2012), 6424–6434.
28. Chen, J., Li, Y., Yu, T.-S., McKay, R.M., Burns, D.K., Kernie, S.G., Parada, L.F., A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488 (2012), 522–526.
29. Chen, X., Zhang, M., Zhou, C., Kallenbach, N.R., Ren, D., Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl. Environ. Microbiol. 77 (2011), 4878–4885.
30. Cheverton, A.M., Gollan, B., Przydacz, M., Wong, C.T., Mylona, A., Hare, S.A., Helaine, S., A Salmonella toxin promotes persister formation through acetylation of tRNA. Mol. Cell, 2016, 10.1016/j.molcel.2016.05.002.
31. Chowdhury, N., Wood, T.L., Martínez-Vázquez, M., García-Contreras, R., Wood, T.K., DNA-crosslinker cisplatin eradicates bacterial persister cells. Biotechnol. Bioeng., 2016, 10.1002/bit.25963.
32. Christensen, L.D., Van Gennip, M., Jakobsen, T.H., Alhede, M., Hougen, H.P., Høiby, N., Bjarnsholt, T., Givskov, M., Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J. Antimicrob. Chemother. 67 (2012), 1198–1206.
33. Claudi, B., Spröte, P., Chirkova, A., Personnic, N., Zankl, J., Schürmann, N., Schmidt, A., Bumann, D., Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158 (2014), 722–733.
34. Cohen, N.R., Lobritz, M.A., Collins, J.J., Microbial persistence and the road to drug resistance. Cell Host Microbe 13 (2013), 632–642.
35. Conlon, B.P., Nakayasu, E.S., Fleck, L.E., LaFleur, M.D., Isabella, V.M., Coleman, K., Leonard, S.N., Smith, R.D., Adkins, J.N., Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503 (2013), 365–370.
36. Conlon, B.P., Rowe, S.E., Gandt, A.B., Nuxoll, A.S., Donegan, N.P., Zalis, E.A., Clair, G., Adkins, J.N., Cheung, A.L., Lewis, K., Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat. Microbiol., 1, 2016, 16051.
37. Costerton, J.W., Bacterial biofilms: a common cause of persistent infections. Science 284 (1999), 1318–1322.
38. Dalebroux, Z.D., Svensson, S.L., Gaynor, E.C., Swanson, M.S., ppGpp conjures bacterial virulence. Microbiol. Mol. Biol. Rev. 74 (2010), 171–199.
39. De Groote, V.N., Fauvart, M., Kint, C.I., Verstraeten, N., Jans, A., Cornelis, P., Michiels, J., Pseudomonas aeruginosa fosfomycin resistance mechanisms affect non-inherited fluoroquinolone tolerance. J. Med. Microbiol. 60 (2011), 329–336.
40. De Groote, V.N., Verstraeten, N., Fauvart, M., Kint, C.I., Verbeeck, A.M., Beullens, S., Cornelis, P., Michiels, J., Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 297 (2009), 73–79.
41. ® Art-175 against resistant and persistent Acinetobacter baumannii. Antimicrob. Agents Chemother. 60 (2016), 3480–3488.
42. Dhar, N., McKinney, J.D., Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 12275–12280.
43. Dhar, N., McKinney, J.D., Microbial phenotypic heterogeneity and antibiotic tolerance. Curr. Opin. Microbiol. 10 (2007), 30–38.
44. Diard, M., Sellin, M.E., Dolowschiak, T., Arnoldini, M., Ackermann, M., Hardt, W.-D., Antibiotic treatment selects for cooperative virulence of Salmonella Typhimurium. Curr. Biol. 24 (2014), 2000–2005.
45. Dörr, T., Lewis, K., Vulić, M., SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet., 5, 2009, e1000760.
46. Dörr, T., Vulić, M., Lewis, K., Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol., 8, 2010, e1000317.
47. Driffield, K., Miller, K., Bostock, J.M., O'Neill, A.J., Chopra, I., Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrob. Chemother. 61 (2008), 1053–1056.
48. Duan, X., Huang, X., Wang, X., Yan, S., Guo, S., Abdalla, A.E., Huang, C., Xie, J., l-Serine potentiates fluoroquinolone activity against Escherichia coli by enhancing endogenous reactive oxygen species production. J. Antimicrob. Chemother., 2016 dkw114.
49. Ejrnaes, K., Sandvang, D., Lundgren, B., Holm, S., Monsen, T., Lundholm, R., Ferry, S., Frimodt-moller, N., Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J. Clin. Microbiol. 44 (2006), 1776–1781.
50. Eldar, A., Elowitz, M.B., Functional roles for noise in genetic circuits. Nature 467 (2010), 167–173.
51. Elowitz, M.B., Levine, A.J., Siggia, E.D., Swain, P.S., Stochastic gene expression in a single cell. Science 297 (2002), 1183–1186.
52. Eng, R.H., Padberg, F.T., Smith, S.M., Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob. Agents Chemother. 35 (1991), 1824–1828.
53. Eyler, C.E., Rich, J.N., Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol. 26 (2008), 2839–2845.
54. Fauvart, M., De Groote, V.N., Michiels, J., Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 60 (2011), 699–709.
55. Filkins, L.M., O'Toole, G.A., Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS Pathog., 11, 2015, e1005258.
56. Ford, A., Mansur, M.B., Furness, C.L., van Delft, F.W., Okamura, J., Suzuki, T., Kobayashi, H., Kaneko, Y., Greaves, M., Protracted dormancy of pre-leukaemic stem cells. Leukemia 29 (2015), 2202–2207.
57. Foster, P.L., Stress-induced mutagenesis in bacteria. Crit. Rev. Biochem. Mol. Biol. 42 (2007), 373–397.
58. Foxman, B., Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49 (2003), 53–70.
59. Fridman, O., Goldberg, A., Ronin, I., Shoresh, N., Balaban, N.Q., Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 99 (2014), 418–421.
60. Fung, D.K.C., Chan, E.W.C., Chin, M.L., Chan, R.C.Y., Delineation of a bacterial starvation stress response network which can mediate antibiotic tolerance development. Antimicrob. Agents Chemother. 54 (2010), 1082–1093.
61. Gardner, A., West, S.A., Griffin, A.S., Is bacterial persistence a social trait?. PLoS ONE, 2, 2007, e752.
62. Gefen, O., Gabay, C., Mumcuoglu, M., Engel, G., Balaban, N.Q., Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 6145–6149.
63. Gerdes, K., Rasmussen, P.B., Molin, S., Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 3116–3120.
64. Germain, E., Castro-Roa, D., Zenkin, N., Gerdes, K., Molecular mechanism of bacterial persistence by HipA. Mol. Cell 52 (2013), 1–7.
65. Girgis, H.S., Harris, K., Tavazoie, S., Large mutational target size for rapid emergence of bacterial persistence. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 12740–12745.
66. Glickman, M.S., Sawyers, C.L., Converting cancer therapies into cures: lessons from infectious diseases. Cell 148 (2012), 1089–1098.
67. Goneau, L.W., Yeoh, N.S., Macdonald, K.W., Cadieux, P.A., Burton, J.P., Razvi, H., Reid, G., Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob. Agents Chemother. 58 (2014), 2089–2097.
68. Gonzalez-Escobedo, G., Marshall, J.M., Gunn, J.S., Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nat. Rev. Microbiol. 9 (2011), 9–14.
69. Gordon, M.A., Banda, H.T., Gondwe, M., Gordon, S.B., Boeree, M.J., Walsh, A.L., Corkill, J.E., Hart, C.A., Gilks, C.F., Molyneux, M.E., Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16 (2002), 1633–1641.
70. Gotoh, H., Kasaraneni, N., Devineni, N., Dallo, S.F., Weitao, T., SOS involvement in stress-inducible biofilm formation. Biofouling 26 (2010), 603–611.
71. Hall-Stoodley, L., Costerton, J.W., Stoodley, P., Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2 (2004), 95–108.
72. Hansen, S., Lewis, K., Vulić, M., Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents Chemother. 52 (2008), 2718–2726.
73. Hata, A.N., Niederst, M.J., Archibald, H.L., Gomez-caraballo, M., Siddiqui, F.M., Mulvey, H.E., Maruvka, Y.E., Ji, F., Bhang, H.C., Krishnamurthy Radhakrishna, V., Siravegna, G., Hu, H., Raoof, S., Lockerman, E., Kalsy, A., Lee, D., Keating, C.L., Ruddy, D.A., Damon, L.J., Crystal, A.S., Costa, C., Piotrowska, Z., Bardelli, A., Iafrate, A.J., Sadreyev, R.I., Stegmeier, F., Getz, G., Sequist, L.V., Faber, A.C., Engelman, J.A., Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition. Nat. Med. 22 (2016), 262–269.
74. Helaine, S., Cheverton, A.M., Watson, K.G., Faure, L.M., Matthews, S.A., Holden, D.W., Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343 (2014), 204–208.
75. Hobby, G., Meyer, K., Chaffee, E., Observations on the mechanism of action of penicillin. Exp. Biol. Med. 50 (1942), 281–285.
76. Hofsteenge, N., van Nimwegen, E., Silander, O.K., Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli. BMC Microbiol., 13, 2013, 25.
77. Hong, S.H., Wang, X., O'Connor, H.F., Benedik, M.J., Wood, T.K., Bacterial persistence increases as environmental fitness decreases. Microb. Biotechnol. 5 (2012), 509–522.
78. Hu, Y., Coates, A.R.M., Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol. Lett. 243 (2005), 117–124.
79. Hu, Y., Kwan, B.W., Osbourne, D.O., Benedik, M.J., Wood, T.K., Toxin YafQ increases persister cell formation by reducing indole signaling. Environ. Microbiol. 17 (2014), 1275–1285.
80. Hunstad, D.A., Justice, S.S., Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu. Rev. Microbiol. 64 (2010), 203–221.
81. Jansen, G., Barbosa, C., Schulenburg, H., Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance. Drug Resist. Updat. 16 (2013), 93–107.
82. Jenkins, S.G., Schuetz, A.N., Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clin. Proc. 87 (2012), 290–308.
83. Jiafeng, L., Fu, X., Chang, Z., Hypoionic shock treatment enables aminoglycosides antibiotics to eradicate bacterial persisters. Sci. Rep., 5, 2015, 14247.
84. Johnson, P.J.T., Levin, B.R., Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet., 9, 2013, e1003123.
85. Kaiser, P., Regoes, R.R., Dolowschiak, T., Wotzka, S.Y., Lengefeld, J., Slack, E., Grant, A.J., Ackermann, M., Hardt, W.-D., Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol., 12, 2014, e1001793.
86. Kaspy, I., Rotem, E., Weiss, N., Ronin, I., Balaban, N.Q., Glaser, G., HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat. Commun., 4, 2013, 3001.
87. Keren, I., Kaldalu, N., Spoering, A.L., Wang, Y., Lewis, K., Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230 (2004), 13–18.
88. Keren, I., Minami, S., Rubin, E., Lewis, K., Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio 2 (2011), e00100–e111.
89. Keren, I., Shah, D., Spoering, A.L., Kaldalu, N., Lewis, K., Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186 (2004), 8172–8180.
90. Kim, J.J., Tannock, I.F., Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat. Rev. Cancer 5 (2005), 516–525.
91. Kim, J.-S., Heo, P., Yang, T.-J., Lee, K.-S., Cho, D.-H., Kim, B.T., Suh, J.-H., Lim, H.-J., Shin, D., Kim, S.-K., Kweon, D.-H., Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob. Agents Chemother. 55 (2011), 5380–5383.
92. Kint, C.I., Verstraeten, N., Fauvart, M., Michiels, J., New-found fundamentals of bacterial persistence. Trends Microbiol. 20 (2012), 1–9.
93. Kirstein, J., Hoffmann, A., Lilie, H., Schmidt, R., Helga, R.W., Heike, B.O., Mogk, A., Turgay, K., Rübsamen-Waigmann, H., Brötz-Oesterhelt, H., Mogk, A., Kürsad, T., The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol. Med. 1 (2009), 37–49.
94. Knoechel, B., Roderick, J.E., Williamson, K.E., Zhu, J., Lohr, J.G., Cotton, M.J., Gillespie, S.M., Fernandez, D., Ku, M., Wang, H., Piccioni, F., Silver, S.J., Jain, M., Pearson, D., Kluk, M.J., Ott, C.J., Shultz, L.D., Brehm, M.A., Greiner, D.L., Gutierrez, A., Stegmaier, K., Kung, A.L., Root, D.E., Bradner, J.E., Aster, J.C., Kelliher, M.A., Bernstein, B.E., An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat. Genet. 46 (2014), 364–370.
95. Korch, S.B., Henderson, T.A., Hill, T.M., Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50 (2003), 1199–1213.
96. Korch, S.B., Hill, T.M., Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188 (2006), 3826–3836.
97. Kussell, E., Kishony, R., Balaban, N.Q., Leibler, S., Bacterial persistence: a model of survival in changing environments. Genetics 169 (2005), 1807–1814.
98. Kwaik, Y.A., Bumann, D., Microbial quest for food in vivo: “nutritional virulence” as an emerging paradigm. Cell. Microbiol. 15 (2013), 882–890.
99. Kwan, B.W., Chowdhury, N., Wood, T.K., Combatting bacterial infections by killing persister cells with mitomycin C. Environ. Microbiol. 17 (2015), 4406–4414.
100. Kwan, B.W., Valenta, J.A., Benedik, M.J., Wood, T.K., Arrested protein synthesis increases persister-like cell formation. Antimicrob. Agents Chemother. 57 (2013), 1468–1473.
101. LaFleur, M.D., Kumamoto, C.A., Lewis, K., Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50 (2006), 3839–3846.
102. Lambert, G., Estévez-salmeron, L., Oh, S., Liao, D., Emerson, B.M., Tlsty, T.D., Austin, R.H., An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat. Rev. Cancer 11 (2011), 375–382.
103. Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa-Fekete, R., Bogos, B., Méhi, O., Csörgő, B., Pósfai, G., Fekete, G., Szappanos, B., Kégl, B., Papp, B., Pál, C., Bacterial evolution of antibiotic hypersensitivity. Mol. Syst. Biol., 9, 2013, 700.
104. Lebeaux, D., Chauhan, A., pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J. Infect. Dis. 210 (2014), 1357–1366.
105. Leung, V., Lévesque, C.M., A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J. Bacteriol. 194 (2012), 2265–2274.
106. Levin, B.R., Concepción-Acevedo, J., Udekwu, K.I., Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr. Opin. Microbiol. 21 (2014), 18–21.
107. Levin, B.R., Rozen, D.E., Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4 (2006), 556–562.
108. Lewis, K., Persister cells. Annu. Rev. Microbiol. 64 (2010), 357–372.
109. Lewis, K., Riddle of Biofilm Resistance. Antimicrob. Agents Chemother. 45 (2001), 999–1007.
110. Li, T., Yin, N., Liu, H., Pei, J., Lai, L., Novel inhibitors of toxin HipA reduce multidrug tolerant persisters. ACS Med. Chem. Lett. 7 (2016), 449–453.
111. Li, X.-Z., Nikaido, H., Efflux-mediated drug resistance in bacteria: an update. Drugs 69 (2009), 1555–1623.
112. Li, Y., Zhang, Y., PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob. Agents Chemother. 51 (2007), 2092–2099.
113. Liu, H.H., Tomasz, A., Penicillin tolerance in multiply drug-resistant neutral isolates of Streptococcus pneumoniae. J. Infect. Dis. 152 (1985), 365–372.
114. Loewe, L., Textor, V., Scherer, S., High deleterious genomic mutation rate in stationary phase of Escherichia coli. Science 302 (2003), 1558–1560.
115. Ma, C., Sim, S., Shi, W., Du, L., Xing, D., Zhang, Y., Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiol. Lett. 303 (2010), 33–40.
116. Maisonneuve, E., Castro-Camargo, M., Gerdes, K., (p)ppGpp controls bacterial persistence by stochastic induction of toxin–antitoxin activity. Cell 154 (2013), 1140–1150.
117. Maisonneuve, E., Gerdes, K., Molecular mechanisms underlying bacterial persisters. Cell 157 (2014), 539–548.
118. Maisonneuve, E., Shakespeare, L.J., Girke, M., Gerdes, K., Bacterial persistence by RNA endonucleases. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 13206–13211.
119. Manina, G., Dhar, N., McKinney, J.D., Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host Microbe 17 (2015), 32–46.
120. Manina, G., McKinney, J., A single-cell perspective on non-growing but metabolically active (NGMA) bacteria. Curr. Top. Microbiol. Immunol. 374 (2013), 135–161.
121. Mccune, R.M., Tompsett, R., Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J. Exp. Med. 104 (1956), 737–762.
122. Mechler, L., Herbig, A., Paprotka, K., Fraunholz, M., Nieselt, K., Bertram, R., A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus. Antimicrob. Agents Chemother. 59 (2015), 5366–5376.
123. Medaney, F., Dimitriu, T., Ellis, R.J., Raymond, B., Live to cheat another day: bacterial dormancy facilitates the social exploitation of β-lactamases. ISME J. 10 (2015), 778–787.
124. Menchón, S.A., Condat, C.A., Quiescent cells: a natural way to resist chemotherapy. Physica A 390 (2011), 3354–3361.
125. Michiels, J.E., Van den Bergh, B., Verstraeten, N., Fauvart, M., Michiels, J., In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob. Agents Chemother. AAC, 2016 00757-16.
126. Möker, N., Dean, C.R., Tao, J., Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J. Bacteriol. 192 (2010), 1946–1955.
127. Mordukhova, E.A., Pan, J.-G., Stabilization of homoserine-O-cuccinyltransferase (MetA) decreases the frequency of persisters in Escherichia coli under stressful conditions. PLOS ONE, 9, 2014, e110504.
128. Moyed, H.S., Bertrand, K.P., hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155 (1983), 768–775.
129. Mulcahy, L.R., Burns, J.L., Lory, S., Lewis, K., Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192 (2010), 6191–6199.
130. Murakami, K., Ono, T., Viducic, D., Kayama, S., Mori, M., Hirota, K., Nemoto, K., Miyake, Y., Role for rpoS gene of Pseudomonas aeruginosa in antibiotic tolerance. FEMS Microbiol. Lett. 242 (2005), 161–167.
131. Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., Britigan, B.E., Singh, P.K., Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334 (2011), 982–986.
132. Novak, R., Henriques, B., Charpentier, E., Normark, S., Tuomanen, E., Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 399 (1999), 590–593.
133. Okoro, C.K., Kingsley, R.A., Quail, M.A., Kankwatira, A.M., Feasey, N.A., Parkhill, J., Dougan, G., Gordon, M.A., High-resolution single nucleotide polymorphism analysis distinguishes recrudescence and reinfection in recurrent invasive nontyphoidal Salmonella Typhimurium disease. Clin. Infect. Dis. 54 (2012), 955–963.
134. Orman, M.A., Brynildsen, M.P., Inhibition of stationary phase respiration impairs persister formation in E. coli. Nat. Commun., 6, 2015, 7983.
135. Orman, M.A., Brynildsen, M.P., Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57 (2013), 3230–3239.
136. Oxnard, G.R., The cellular origins of drug resistance in cancer. Nat. Med. 22 (2016), 232–234.
137. Page, R., Peti, W., Toxin–antitoxin systems in bacterial growth arrest and persistence. Nat. Chem. Biol. 12 (2016), 208–214.
138. Patra, P., Klumpp, S., Population dynamics of bacterial persistence. PLOS ONE, 8, 2013, e62814.
139. Pearl, S., Gabay, C., Kishony, R., Oppenheim, A., Balaban, N.Q., Nongenetic individuality in the host-phage interaction. PLoS Biol., 6, 2008, e120.
140. Pedersen, K., Christensen, S.K., Gerdes, K., Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45 (2002), 501–510.
141. Persky, N.S., Ferullo, D.J., Cooper, D.L., Moore, H.R., Lovett, S.T., The ObgE/CgtA GTPase influences the stringent response to amino acid starvation in Escherichia coli. Mol. Microbiol. 73 (2009), 253–266.
142. Prax, M., Mechler, L., Weidenmaier, C., Bertram, R., Glucose augments killing efficiency of daptomycin challenged Staphylococcus aureus persisters. PLOS ONE, 11, 2016, e0150907.
143. Price, K.E., Orazi, G., Ruoff, K.L., Hebert, W.P., O'Toole, G.A., Mastoridis, P., Mannitol does not enhance tobramycin killing of Pseudomonas aeruginosa in a cystic fibrosis model system of biofilm formation. PLOS ONE, 10, 2015, e0141192.
144. Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M.A.B., Ge, H., Sun, Y., Xie, X.S., Bai, F., Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol. Cell 62 (2016), 284–294.
145. Putrinš, M., Kogermann, K., Lukk, E., Lippus, M., Varik, V., Tenson, T., Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement. Infect. Immun. 83 (2015), 1056–1067.
146. Raha, D., Wilson, T.R., Peng, J., Peterson, D., Yue, P., Evangelista, M., Wilson, C., Merchant, M., Settleman, J., The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer Res. 74 (2014), 3579–3590.
147. Ramirez, M., Rajaram, S., Steininger, R.J., Osipchuk, D., Roth, M.A., Morinishi, L.S., Evans, L., Ji, W., Hsu, C.-H., Thurley, K., Wei, S., Zhou, A., Koduru, P.R., Posner, B.A., Wu, L.F., Altschuler, S.J., Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat. Commun., 7, 2016, 10690.
148. Ren, H., He, X., Zou, X., Wang, G., Li, S., Wu, Y., Gradual increase in antibiotic concentration affects persistence of Klebsiella pneumoniae. J. Antimicrob. Chemother. 70 (2015), 3267–3272.
149. Rotem, E., Loinger, A., Ronin, I., Levin-Reisman, I., Gabay, C., Shoresh, N., Biham, O., Balaban, N.Q., Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 12541–12546.
150. Rutherford, S.T., Bassler, B.L., Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb. Perspect. Med., 2, 2012, a012427.
151. Ryder, V.J., Chopra, I., O'Neill, A.J., Increased mutability of staphylococci in biofilms as a consequence of oxidative stress. PLoS ONE, 7, 2012, e47695.
152. Salama, N.R., Hartung, M.L., Müller, A., Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11 (2013), 385–399.
153. Sampson, S.L., Helaine, S., Holden, D.W., Sampson, S.L., Elucidating population-wide mycobacterial replication dynamics at the single-cell level. Microbiology, 2016, 10.1099/mic.0.000288.
154. Savage, V.J., Chopra, I., O'Neill, A.J., Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob. Agents Chemother. 57 (2013), 1968–1970.
155. Schumacher, M.A., Balani, P., Min, J., Chinnam, N.B., Hansen, S., Vulić, M., Lewis, K., Brennan, R.G., HipBA–promoter structures reveal the basis of heritable multidrug tolerance. Nature 524 (2015), 59–64.
156. Schumacher, M.A., Min, J., Link, T.M., Guan, Z., Xu, W., Ahn, Y.-H., Soderblom, E.J., Kurie, J.M., Evdokimov, A., Moseley, M.A., Lewis, K., Brennan, R.G., Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug tolerance. Cell Rep. 2 (2012), 518–525.
157. Shah, D., Zhang, Z., Khodursky, A., Kaldalu, N., Kurg, K., Lewis, K., Persisters: a distinct physiological state of E. coli. BMC Microbiol., 6, 2006, 53.
158. Shan, Y., Lazinski, D., Rowe, S., Camilli, A., Lewis, K., Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. MBio, 6, 2015 e00078-15.
159. Sharma, B., Brown, A.V., Matluck, N.E., Hu, L.T., Lewis, K., Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells. Antimicrob. Agents Chemother. 59 (2015), 4616–4624.
160. Sharma, S.V., Lee, D.Y., Li, B., Quinlan, M.P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M.A., Wong, K.-K., Brandstetter, K., Wittner, B., Ramaswamy, S., Classon, M., Settleman, J., A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141 (2010), 69–80.
161. Slattery, A., Victorsen, A.H., Brown, A., Hillman, K., Phillips, G.J., Isolation of highly persistent mutants of Salmonella enterica serovar Typhimurium reveals a new toxin–antitoxin module. J. Bacteriol. 195 (2013), 647–657.
162. Smits, W.K., Kuipers, O.P., Veening, J.-W., Phenotypic variation in bacteria: the role of feedback regulation. Nat. Rev. Microbiol. 4 (2006), 259–271.
163. Spoering, A.L., Lewis, K., Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183 (2001), 6746–6751.
164. Spoering, A.L., Vulic, M., Lewis, K., Vulić, M., Lewis, K., GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 188 (2006), 5136–5144.
165. Sprouffske, K., Merlo, L.M.F., Gerrish, P.J., Maley, C.C., Sniegowski, P.D., Cancer in light of experimental evolution. Curr. Biol. 22 (2012), R762–R771.
166. Stankowicz, M.S., Ibrahim, J., Brown, D.L., Once-daily aminoglycoside dosing: an update on current literature. Am. J. Heal. Pharm. 72 (2015), 1357–1364.
167. Stepanyan, K., Wenseleers, T., Duéñez-Guzmán, E.A., Muratori, F., Van den Bergh, B., Verstraeten, N., De Meester, L., Verstrepen, K.J., Fauvart, M., Michiels, J., Fitness trade-offs explain low levels of persister cells in the opportunistic pathogen Pseudomonas aeruginosa. Mol. Ecol. 24 (2015), 1572–1583.
168. Stewart, B., Rozen, D.E., Genetic variation for antibiotic persistence in Escherichia coli. Evolution 66 (2011), 933–939.
169. Sturm, A., Heinemann, M., Arnoldini, M., Benecke, A., Ackermann, M., Benz, M., Dormann, J., Hardt, W.-D., The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1. PLoS Pathog., 7, 2011, e1002143.
170. Suzuki, S., Horinouchi, T., Furusawa, C., Prediction of antibiotic resistance by gene expression profiles. Nat. Commun., 5, 2014, 5792.
171. Torrey, H.L., Keren, I., Via, L.E., Lee, J.S., Lewis, K., High persister mutants in Mycobacterium tuberculosis. PLoS ONE, 11, 2016, e0155127.
172. Tuomanen, E., Cozens, R., Tosch, W., Zak, O., Tomasz, A., The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J. Gen. Microbiol. 132 (1986), 1297–1304.
173. Unoson, C., Wagner, E.G.H., A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol. Microbiol. 70 (2008), 258–270.
174. Van den Bergh, B., Michiels, J.E., Fauvart, M., Michiels, J., Should we develop screens for multidrug tolerance?. Expert Rev. Anti. Infect. Ther., 2016, 7210.
175. Van den Bergh, B., Michiels, J.E., Wenseleers, T., Windels, E.M., Vanden Boer, P., Kestemont, D., De Meester, L., Verstrepen, K.J., Verstraeten, N., Fauvart, M., Michiels, J., Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat. Microbiol., 1, 2016, 16020.
176. Van Melderen, L., Toxin–antitoxin systems: why so many, what for?. Curr. Opin. Microbiol. 13 (2010), 781–785.
177. Vázquez-Laslop, N., Lee, H., Neyfakh, A.A., Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188 (2006), 3494–3497.
178. Veening, J.-W., Smits, W.K., Kuipers, O.P., Bistability, epigenetics, and bet-hedging in bacteria. Annu. Rev. Microbiol. 62 (2008), 193–210.
179. Vega, N.M., Allison, K.R., Khalil, A.S., Collins, J.J., Signaling-mediated bacterial persister formation. Nat. Chem. Biol. 8 (2012), 431–433.
180. Vega, N.M., Allison, K.R., Samuels, A.N., Klempner, M.S., Collins, J.J., Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 14420–14425.
181. Verstraeten, N., Knapen, W., Fauvart, M., Michiels, J., A historical perspective on bacterial persistence. Methods in Molecular Biology, 2016, Springer Science, New York, 3–13.
182. Verstraeten, N., Knapen, W., Fauvart, M., Michiels, J., Membrane depolarization-triggered responsive diversification leads to antibiotic tolerance. Microb. Cell 2 (2015), 299–301.
183. Verstraeten, N., Knapen, W.J., Kint, C.I., Liebens, V., Van den Bergh, B., Dewachter, L., Michiels, J.E., Fu, Q., David, C.C., Fierro, C.A., Marchal, K., Beirlant, J., Versées, W., Hofkens, J., Jansen, M., Fauvart, M., Michiels, J., Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Mol. Cell 59 (2015), 9–21.
184. Vinogradova, M., Gehling, V.S., Gustafson, A., Arora, S., Tindell, C.A., Wilson, C., Williamson, K.E., Guler, G.D., Gangurde, P., Manieri, W., Busby, J., Flynn, E.M., Lan, F., Kim, H., Odate, S., Cochran, A.G., Liu, Y., Wongchenko, M., Yang, Y., Cheung, T.K., Maile, T.M., Lau, T., Costa, M., Hegde, G.V., Jackson, E., Pitti, R., Arnott, D., Bailey, C., Bellon, S., Cummings, R.T., Albrecht, B.K., Harmange, J.-C., Kiefer, J.R., Trojer, P., Classon, M., An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nat. Chem. Biol. 12 (2016), 531–538.
185. Vogwill, T., Comfort, A.C., Furió, V., MaClean, R.C., Persistence and resistance as complementary bacterial adaptations to antibiotics. J. Evol. Biol. 29 (2016), 1223–1233.
186. Wakamoto, Y., Dhar, N., Chait, R., Schneider, K., Signorino-Gelo, F., Leibler, S., McKinney, J.D., Dynamic persistence of antibiotic-stressed mycobacteria. Science 339 (2013), 91–95.
187. Wang, X., Wood, T.K., Toxin–antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 77 (2011), 5577–5583.
188. Wen, Y., Behiels, E., Devreese, B., Toxin–antitoxin systems: their role in persistence, biofilm formation, and pathogenicity. Pathog. Dis. 70 (2014), 240–249.
189. Wicha, M.S., Liu, S., Dontu, G., Cancer stem cells: an old idea — a paradigm shift. Cancer Res. 66 (2006), 1883–1891.
190. Wiuff, C., Andersson, D.I., Antibiotic treatment in vitro of phenotypically tolerant bacterial populations. J. Antimicrob. Chemother. 59 (2007), 254–263.
191. Wiuff, C., Zappala, R., Regoes, R.R., Garner, K., Baquero, F., Levin, B.R., Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49 (2005), 1438–1494.
192. Wood, T.K., Knabel, S.J., Kwan, B.W., Bacterial persister cell formation and dormancy. Appl. Environ. Microbiol. 79 (2013), 7116–7121.
193. World Health Organization, Antimicrobial Resistance: Global Report on Surveillance., 2014, WHO, Geneva, Switzerland.
194. Wu, N., He, L., Cui, P., Wang, W., Yuan, Y., Liu, S., Xu, T., Zhang, S., Wu, J., Zhang, W., Zhang, Y., Ranking of persister genes in the same Escherichia coli genetic background demonstrates varying importance of individual persister genes in tolerance to different antibiotics. Front. Microbiol., 6, 2015, 1003.
195. Wu, Y., Vulic, M., Keren, I., Lewis, K., Role of oxidative stress in persister tolerance. Antimicrob. Agents Chemother. 56 (2012), 4922–4926.
196. Yang, Y., Bazhin, A.V., Werner, J., Karakhanova, S., Reactive oxygen species in the immune system. Int. Rev. Immunol. 32 (2013), 249–270.